HomeCompareSLGCW vs CL

SLGCW vs CL: Dividend Comparison 2026

SLGCW yields 2325.58% · CL yields 2.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SLGCW wins by $40776875559.48M in total portfolio value
10 years
SLGCW
SLGCW
● Live price
2325.58%
Share price
$0.09
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40776875559.52M
Annual income
$37,596,667,161,556,740.00
Full SLGCW calculator →
CL
CL
● Live price
2.44%
Share price
$85.23
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$41.0K
Annual income
$5,451.69
Full CL calculator →

Portfolio growth — SLGCW vs CL

📍 SLGCW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSLGCWCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SLGCW + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SLGCW pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SLGCW
Annual income on $10K today (after 15% tax)
$197,674.42/yr
After 10yr DRIP, annual income (after tax)
$31,957,167,087,323,224.00/yr
CL
Annual income on $10K today (after 15% tax)
$207.44/yr
After 10yr DRIP, annual income (after tax)
$4,633.94/yr
At 15% tax rate, SLGCW beats the other by $31,957,167,087,318,590.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SLGCW + CL for your $10,000?

SLGCW: 50%CL: 50%
100% CL50/50100% SLGCW
Portfolio after 10yr
$20388437779.78M
Annual income
$18,798,333,580,781,092.00/yr
Blended yield
92.20%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

SLGCW
Analyst Ratings
4
Buy
2
Hold
Consensus: Buy
Altman Z
2.1
Piotroski
2/9
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+8.5% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SLGCW buys
0
CL buys
0
No recent congressional trades found for SLGCW or CL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSLGCWCL
Forward yield2325.58%2.44%
Annual dividend / share$2.00$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28.6%
Portfolio after 10y$40776875559.52M$41.0K
Annual income after 10y$37,596,667,161,556,740.00$5,451.69
Total dividends collected$40553604915.26M$18.1K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyHold

Year-by-year: SLGCW vs CL ($10,000, DRIP)

YearSLGCW PortfolioSLGCW Income/yrCL PortfolioCL Income/yrGap
1← crossover$243,258$232,558.14$11,014$313.84+$232.2KSLGCW
2$5,547,357$5,287,071.06$12,200$415.44+$5.54MSLGCW
3$118,616,525$112,680,853.02$13,607$553.09+$118.60MSLGCW
4$2,378,696,839$2,251,777,157.33$15,301$741.41+$2378.68MSLGCW
5$44,747,448,169$42,202,242,550.89$17,374$1,002.00+$44747.43MSLGCW
6$789,840,516,324$741,960,746,783.42$19,958$1,367.44+$789840.50MSLGCW
7$13,084,759,261,953$12,239,629,909,486.39$23,243$1,887.87+$13084759.24MSLGCW
8$203,501,400,619,673$189,500,708,209,383.28$27,512$2,642.43+$203501400.59MSLGCW
9$2,972,157,381,276,708$2,754,410,882,613,657.00$33,197$3,759.22+$2972157381.24MSLGCW
10$40,776,875,559,522,820$37,596,667,161,556,740.00$40,973$5,451.69+$40776875559.48MSLGCW

SLGCW vs CL: Complete Analysis 2026

SLGCWStock

SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. The company's SOMAmers/SomaScan technology enables researchers to analyze various types of biological samples for protein biomarker signatures, which can be utilized in drug discovery and development. Its SomaScan's biomarker discoveries help in diagnostic applications in various areas of diseases, including cardiovascular and metabolic disease, nonalcoholic steatohepatitis, wellness, and others. The company also provides SomaSignal research use only and laboratory-developed tests. It serves research and clinical customers with a focus on pharmaceutical and biotechnology companies, and academic research institutions, as well as facilitates drug development, analysis of clinical trials, and new human biology insights by assessing protein-protein and protein-gene networks. The company was incorporated in 1999 and is headquartered in Boulder, Colorado.

Full SLGCW Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this SLGCW vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SLGCW vs SCHDSLGCW vs JEPISLGCW vs OSLGCW vs KOSLGCW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.